Cerebellar contributions to sequence prediction in verbal working memory

por Peterburs, Jutta, Blevins, Laura C., Sheu, Yi-Shin, Desmond, John E.
Publicado 2018

Fast Acting Insulin Aspart Compared with Insulin Aspart in the Medtronic 670G Hybrid Closed Loop System in Type 1 Diabetes: An Open Label Crossover Study

por Ozer, Kerem, Cooper, Alison M., Ahn, Lily P., Waggonner, Cassidy R., Blevins, Thomas C.
Publicado 2021

Efficacy and safety of MYL‐1501D versus insulin glargine in people with type 1 diabetes mellitus: Results of the INSTRIDE 3 phase 3 switch study

por Blevins, Thomas C., Barve, Abhijit, Raiter, Yaron, Aubonnet, Patrick, Athalye, Sandeep, Sun, Bin, Muniz, Rafael
Publicado 2019

Fixed‐ratio combination of insulin degludec and liraglutide (IDegLira) improves cardiovascular risk markers in patients with type 2 diabetes uncontrolled on basal insulin

por Vilsbøll, Tina, Blevins, Thomas C., Jodar, Esteban, Poulter, Neil, Tentolouris, Nikolaos, Ross Agner, Bue F., Lehmann, Lucine, Leiter, Lawrence A.
Publicado 2019

Immunogenicity, Efficacy, and Safety of Biosimilar Insulin Aspart (MYL-1601D) Compared with Originator Insulin Aspart (Novolog(®)) in Patients with Type 1 Diabetes After 24 Weeks:...

por Blevins, Thomas C., Raiter, Yaron, Sun, Bin, Donnelly, Charles, Shapiro, Roxann, Chullikana, Anoop, Rao, Anita, Vashishta, Laxmikant, Ranganna, Gopinath, Barve, Abhijit
Publicado 2022

Comparison of insulin lispro protamine suspension versus insulin glargine once daily added to oral antihyperglycaemic medications and exenatide in type 2 diabetes: a prospective ra...

por Arakaki, R F, Blevins, T C, Wise, J K, Liljenquist, D R, Jiang, H H, Jacobson, J G, Martin, S A, Jackson, J A
Publicado 2014

Better Glycemic Control and Weight Loss With the Novel Long-Acting Basal Insulin LY2605541 Compared With Insulin Glargine in Type 1 Diabetes: A randomized, crossover study

por Rosenstock, Julio, Bergenstal, Richard M., Blevins, Thomas C., Morrow, Linda A., Prince, Melvin J., Qu, Yongming, Sinha, Vikram P., Howey, Daniel C., Jacober, Scott J.
Publicado 2013

Evaluation of immunogenicity of LY2963016 insulin glargine compared with Lantus® insulin glargine in patients with type 1 or type 2 diabetes mellitus

por Ilag, L. L., Deeg, M. A., Costigan, T., Hollander, P., Blevins, T. C., Edelman, S. V., Konrad, R. J., Ortmann, R. A., Pollom, R. K., Huster, W. J., Zielonka, J. S., Prince, M. J.
Publicado 2016

Anatabine Supplementation Decreases Thyroglobulin Antibodies in Patients With Chronic Lymphocytic Autoimmune (Hashimoto's) Thyroiditis: A Randomized Controlled Clinical Trial

por Schmeltz, Lowell R., Blevins, Thomas C., Aronoff, Stephen L., Ozer, Kerem, Leffert, Jonathan D., Goldberg, Marc A., Horowitz, Barry S., Bertenshaw, Richard H., Troya, Pedro, Cohen, Amy E., Lanier, Ryan K., Wright, Curtis
Publicado 2014

Preoperative Identification of Medullary Thyroid Carcinoma (MTC): Clinical Validation of the Afirma MTC RNA-Sequencing Classifier

por Randolph, Gregory W., Sosa, Julie Ann, Hao, Yangyang, Angell, Trevor E., Shonka, David C., LiVolsi, Virginia A., Ladenson, Paul W., Blevins, Thomas C., Duh, Quan-Yang, Ghossein, Ronald, Harrell, Mack, Patel, Kepal Narendra, Shanik, Michael H., Traweek, S. Thomas, Walsh, P. Sean, Yeh, Michael W., Abdelhamid Ahmed, Amr H., Ho, Allen S., Wong, Richard J., Klopper, Joshua P., Huang, Jing, Kennedy, Giulia C., Kloos, Richard T., Sadow, Peter M.
Publicado 2022